- Conditions
- Spina Bifida; Fetus, Myelomeningocele, Myeloschisis
- Interventions
- NEOX Cord 1K applied fetoscopically
- Device
- Lead sponsor
- The University of Texas Health Science Center, Houston
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2036
- U.S. locations
- 1
- States / cities
- Houston, Texas
Source: ClinicalTrials.gov public record
Updated Aug 12, 2025 · Synced May 21, 2026, 11:10 PM EDT